Haleon Plc: Form 6-K Summary (February 2026)
Business Context and Reporting Period
This Form 6-K, filed on February 25, 2026, announces the preliminary full-year results for Haleon Plc for the year ended December 31, 2025. Haleon is a global leader in consumer health with a portfolio spanning six categories: Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health and Other. The filing serves as a notification that the full results statement is available via the London Stock Exchange and the company's investor website.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references "strong organic operating profit growth" and "strength of FCF generation" but does not quantify these figures in this summary document.
Material Changes and Dividend Proposal
- Dividend Increase: The Board proposes a total 2025 dividend of 7.1p per ordinary share, an increase from the 2024 payout ratio of 37% to approximately 38% of 2025 adjusted earnings.
- Final Dividend: Includes a final dividend of 4.9p per ordinary share.
- Payment Schedule: Subject to shareholder approval, the final dividend is payable on May 14, 2026, to shareholders on the register as of April 10, 2026.
Guidance, Outlook, and Management Commentary
Management highlighted strong free cash flow (FCF) generation and organic operating profit growth as drivers for the proposed dividend. The company expects to grow its ordinary dividend at least in line with adjusted earnings, subject to market conditions and Board approval. A recorded results presentation and Q&A session were scheduled for February 25, 2026, featuring CEO Brian McNamara and CFO Dawn Allen.
Investor Verification Checklist
- Verify the specific revenue, operating profit, and free cash flow figures in the full preliminary results statement linked in the filing.
- Confirm the exact adjusted earnings per share (EPS) to validate the 38% payout ratio calculation.
- Review the full results for details on the "strong organic operating profit growth" mentioned in the summary.
- Check for any specific risk factors or contingencies detailed in the full unedited text submitted to the Financial Conduct Authority.